UK drug firms in Oil for Food investigation
Throughout the sanctions imposed on Iraq since the 1991 Gulf War, continued because of failure of the Iraqi regime to submit to UN inspections, concern had grown about their ill effects on the population of Iraq. In addition, Saddam had deliberately hoarded funds excerbating their adverse effects, in order to generate sympathy for the removal of the sanctions. In 1996, the UN set-up the Oil for Food programme for Iraq to address these problems. Under the scheme oil could be sold, and food, medicine and other humanitarian goods could be obtained in return.
Although the Oil for Food programme had some success in countering in the adverse consequences of the sanctions on the Iraqi people, Saddam found a way to subvert the programme, by bribing individuals by supplying them with vouchers for cheap Iraqi oil. This was done in order to obtain support for lifting UN sanctions. and to create another illicit source of funding for his regime and presumably his series of palaces (most of which were built after 1991).
Those bribed included company executives to prominent politicians from various nations. An independent inquiry committee into the United Nations Oil for food was published in 2005 [PDF], and the associated press release stated that “The value of oil smuggled outside of the Programme is estimated by the Committee to be USD 10.99 billion as opposed to an estimated USD 1.8 billion of illicit revenue from Saddam Husseins manipulation of the Programme.”
The Guardian reports today that three drug companies have been asked to supply confidential information (emails and files) to the Serious Fraud Office (SFO) relating to “dealings in Iraq under the UN oil-for-food programme.”
The move is the latest in the SFO’s 22m investigation into alleged corruption involving UK firms operating in Iraq during the final years of the Saddam Hussein regime. Other companies targeted with similar disclosure demands include several British infrastructure firms.
In a statement, GSK said it did not believe its “employees or its agents in Iraq knowingly engaged in wrongdoing regarding the oil-for-food programme”, adding: “In fact, GSK went to considerable lengths to cooperate with UK government authorities responsible for the UK administration of the programme, and to impose anti-corruption measures when dealing with intermediaries in Iraq.”
AstraZeneca confirmed that a disclosure request had been received and would be fully met. A third drugs firm, the US-based Eli Lilly, which has a UK arm, yesterday said that it too had been asked to supply documents to the SFO.
Last January, the Guardian revealed SFO officials had returned from Washington DC with thousands of documents marking the start of a London-based criminal investigation. This followed a 2005 independent report, commissioned by then UN secretary general, Kofi Annan, into the oil-for-food programme.
The Guardian article goes on to suggest that this may restore the UK’s reputation for dealing with fraud, after the premature end of the SFO’s inquiry into potential corruption involved in a Saudi deal to buy 72 Eurofighter jets from BAE Systems. At the time, Oliver Kamm described this as an unprincipled and stupid decision. These new cases, far from restoring the UK’s reputation, merely highlight that the UK is quite willing to investigate cases which involve a horrendous regime no longer in existence, but choose to avoid investigating a case which involves an appalling regime we continue to do business with. It is a double standard the UK should have avoided at all costs - including lack of Saudi participation in intelligence matters.
Permalink Comments off